Again, the combination of BEMPEG and anti-CTLA-4 treatments with RT reduced tumor growth compared to BEMPEG and anti-CTLA-4 or RT alone (p<0.001, Figure 2E). This evidence concerns the gene CTLA4 and neoplasm.